A study analyzing humoral and cellular immune response against COVID-19 vaccine in non-cirrhotic CLD patients, cirrhotic patients and healthy subjects

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 17 Nov 2022

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

15 Nov 2022 Results assessing the immunogenicity of ChAdOx1 and BBV152 vaccines in patients with CLD (including cirrhosis patients) and LTRs published in the Vaccine
23 Aug 2022 New trial record
26 Jun 2022 Results presented at The International Liver Congress 2022

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com